Praveen Malhotra*, Chitrakshi Bhardwaj, Rajasvi Khurana, Himanshu, Shivanshu, Vikas Singh and Ahsan Khan

Department of Medical Gastroenterology, PGIMS, Rohtak, Haryana, India

*Corresponding Author: Praveen Malhotra, Department of Medical Gastroenterology, PGIMS, Rohtak, Haryana, India

Received: January 24, 2025; Published: March 28, 2025

Abstract

It is well said and proven in literature that important causes of cirrhosis of liver include alcohol intake, metabolic associated fatty liver disease and chronic hepatitis B and C. Less important causes include autoimmune and congenital liver disease, Wilson’s and alpha1 antitrypsin deficiency disease. There can occur gradual progression from chronic hepatitis to cirrhosis and in certain cases can further reach stage of hepatocellular carcinoma. It is said that good clinician can recognize a cirrhotic patient from a distance, as he walks in for consultation, by certain characteristic clinical features associated with cirrhosis of liver. In this article, we have tried to highlight the same.

Keywords: Cirrhosis; Umbilical Hernia; Spider Naevi; Gynaecomastia; Hydrothorax; Caput Medusae

References

1. Bosetti C., et al. “Worldwide mortality from cirrhosis: An update to 2002”. Journal of Hepatology 46 (2007): 827-839.
2. Dunbar JK and Crombie IK. “The rising tide of liver Cirrhosis mortality in the UK: can its halt be predicted?” Alcohol 46 (2011): 459-463.
3. McAvoy NC and Hayes PC. “The cirrhosis epidemic in the UK: evaluating the causes in a European context”. Expert Review of Gastroenterology and Hepatology 1 (2007): 41-45.
4. Thomson SJ., et al. “Chronic liver disease: an increasing problem: a study of hospital admission and mortality rates in England, 1979-2005, with particular reference to alcoholic liver disease”. Alcohol 43 (2008): 416-422.
5. Singh GK and Hoyert DL. “Social epidemiology of chronic liver disease and cirrhosis mortality in the United States, 19351997: trends and differentials by ethnicity, socioeconomic status, and alcohol consumption”. Human Biology 72 (2000): 80120.
6. Vong S and Bell BP. “Chronic liver disease mortality in the United States, 1990-1998”. Hepatology 39 (2004): 476-483.
7. Ray G. “Trends of chronic liver disease in a tertiary care referral hospital in Eastern India”. Indian Journal Public Health 58 (2014): 186-194.
8. Parveen Malhotra., et al. “Chronic Liver Diseases- Experience at Tertiary Care Centre of Northern India”. Journal of Gastroenterology Pancreatology and Hepatobiliary Disorders ().
9. Berman JE and Lamkin BC. “Hepatic disease and the skin”. Dermatologic Clinics 7 (1989): 435-448.
10. Diehl AM. “Alcoholic liver disease”. Medical Clinics of North America 73 (1989): 815-830.
11. Hamilton E. “Mythology: timeless tales of gods and heroes”. New York, NY: New American Library Penguin (1969): 143.
12. Missal ME., et al. “Inferior vena cava obstruction: clinical manifestations, diagnostic methods, and related problems”. Annals of Internal Medicine 62 (1965): 133-161.
13. Nieto AF and Doty DB. “Superior vena cava obstruction: clinical syndrome, aetiology, and treatment”. Current Problems in Cancer 10 (1986): 441-484.
14. Samant H and Kothadia JP. “Stat Pearls”. Stat Pearls Publishing; Treasure Island (FL): Spider Angioma (2023).
15. Gonzalez Ballerga E., et al. “Sublingual microcirculatory alterations in cirrhotic patients”. Microcirculation4 (2018): e12448.
16. Singh S., et al. “Mucocutaneous spider angiomas in an adolescent with chronic liver disease”. Archives of Disease in Childhood 12 (2018): 1145.
17. Yigider AP., et al. “Skin diseases of the nose”. American Journal of Rhinology and Allergy 3 (2016): 83-90.
18. Understanding the Connection Between Cirrhosis and Gynecomastia: Causes, Symptoms, and Treatment Options (2024).
19. Baron HC. “Umbilical hernia secondary to cirrhosis of the liver. Complications of surgical correction”. The New England Journal of Medicine 263 (1960): 824-828.
20. Hansen JB., et al. “Danish nationwide cohort study of postoperative death in patients with liver cirrhosis undergoing hernia repair”. British Journal of Surgery 89 (2002): 805-806.
21. Carbonell AM., et al. “Poor outcomes in cirrhosis-associated hernia repair: a nationwide cohort study of 32,033 patients”. Hernia 9 (2005): 353-357.
22. Chatzizacharias NA., et al. “Successful surgical management of ruptured umbilical hernias in cirrhotic patients”. World Journal of Gastroenterology 21 (2015): 3109-3113.
23. Sarit C., et al. “Minimally invasive repair of recurrent strangulated umbilical hernia in cirrhotic patient with refractory ascites”. Liver transplantation 9 (2003): 621-622.
24. Ammar SA. “Management of complicated umbilical hernias in cirrhotic patients using permanent mesh: randomized clinical trial”. Hernia 14 (2010): 35-38.
25. Dmitry Victorovich Garbuzenko and Nikolay Olegovich Arefyev. “Hepatic hydrothorax: An update and review of the literature”. World Journal of Hepatology 31 (2017): 1197-1204.
26. Garbuzenko DV. “Pathophysiological mechanisms and new directions of therapy of portal hypertension at liver cirrhosis”. Klin Persp Gastrojen Gepatol 6 (2010): 11-20.
27. Pedersen JS., et al. “Management of cirrhotic ascites”. Therapeutic Advances in Chronic Disease 6 (2015): 124-137.
28. Cardenas A., et al. “Review article: hepatic hydrothorax”. Alimentary Pharmacology and Therapeutics 20 (2004): 271-279.

Citation

Citation: Praveen Malhotra., et al. “Back to Basics in Cirrhosis of Liver".Acta Scientific Gastrointestinal Disorders 8.4 (2025): 41-45.

Copyright

Copyright: © 2025 Praveen Malhotra., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.